Novo Nordisk cuts first turf for new insulin purification plant  

The Danish healthcare company has cut the first turf for a new insulin purification plant in Kalundborg, Denmark, to increase its Levemir production

Healthcare company Novo Nordisk has cut the first turf for a new insulin purification factory in Kalundborg, Denmark. The new DKK 800 mn (USD 136 mn) facility is slated for completion during 2006 and is expected to create 100 new jobs. The plant will increase existing production capacity for Levemir, Novo Nordisk' long-acting insulin analogue which was launched earlier this year.


Novo Nordisk inaugurated the world's largest insulin factory in Kalundborg one year ago, and also started the building of a new insulin purification plant equivalent to the one which has just been initiated. In total, Novo Nordisk has three building projects currently underway at its Kalundborg site. Once the combined new facilities are in operation, Novo Nordisk will employ about 2,300 people in the Kalundborg area.


Novo Nordisk is a world leader in diabetes care. The company has the broadest product portfolio in the industry, including advanced products in the area of insulin delivery systems. Novo Nordisk employs about 18,700 people in 68 countries and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London.


Link > Novo Nordisk

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×